Pharmacological properties of traditional medicine (XXIX): Effect of hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 10, 2004, Pages 1599-1603

  Kawashima, Keiko ^a   Nomura, Asano ^a   Makino, Toshiaki ^a   Saito, Ken Ichi ^a   Kano, Yoshihiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

2,4,6 trinitrobenzene sulfonic acid (TNBS) colitis; Baicalin; Berberine; Ginsenosides; Glycyrrhizin; Hange shashin to

Indexed keywords

BAICALIN; BERBERINE; GINSENOSIDE; GLYCYRRHIZIC ACID; HANGE SHASHIN TO; SAPONIN; TRINITROBENZENESULFONIC ACID; ANTIULCER AGENT; HANGE SHASHINTO; HANGE-SHASHINTO; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON; COLON INJURY; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; EXPERIMENTAL MODEL; HERB; MALE; MUCOSAL NECROSIS; NONHUMAN; ORGAN WEIGHT; RAT; SCORING SYSTEM; TRADITIONAL MEDICINE; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; ORAL DRUG ADMINISTRATION; PATHOLOGY; PEPTIC ULCER; PHYTOTHERAPY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ULCER AGENTS; COLITIS; COLON; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; MALE; PEPTIC ULCER; PHYTOTHERAPY; RATS; RATS, WISTAR; TRINITROBENZENESULFONIC ACID;

EID: 21144433069     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1599     Document Type: Article

References (16)

1. Part XXVIII: Makino T., Ito Y., Sasaki S., Fujimura Y., Kano Y., Biol. Pharm. Bull., 27, 554-558 (2004).
2. Naito T., Itoh H., Takeyama M., Biol. Pharm. Bull., 26, 1104-1107 (2003).
3. Naito T., Itoh H., Takeyama M., Biol. Pharm. Bull., 26, 101-104 (2003).
4. Kase Y., Saitoh K., Yuzurihara M., Ishige A., Komatsu Y., Biol. Pharm. Bull., 21, 117-120 (1998).
5. Kase Y., Hayakawa T., Takeda S., Ishige A., Aburada M., Okada M., Biol. Pharm. Bull., 19, 1367-1370 (1996).
6. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallage J. L., Gastroenterol., 96, 795-803 (1989).
7. Wallace J. L., Keenan C. M., Gale D., Shhoupe T. S., Gastroenterol., 1, 18-27 (1992).
8. Goldhill J., Pichat P., Roome N., Angel I., Arbilla S., Arzneim. Forsch. Drug Res., 48, 179-184 (1998).
9. Barbier M., Attoub S., Joubert M., Bado A., Laboisse C., Cherbut C., Galmiche J. P., Life Sci., 69, 567-580 (2001).
10. Campfield L. A., Smith F. J., Guisez Y., Devos R., Burn P., Science, 269, 546-549 (1995).
11. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M., Science, 269, 543-546 (1995).
12. Kase Y., Hayakawa T., Aburada M., Komatsu Y., Kamataki T., Jpn. J. Pharmacol., 75, 407-413 (1997).
13. Kase Y., Saitoh K., Makino B., Hashimoto K., Ishige A., Komatsu Y., Phytother. Res., 13, 468-473 (1999).
14. Kase Y., Saitoh K., Ishige A., Komatsu Y., Biol. Pharm. Bull., 21, 1277-1281 (1998).
15. Zhou H., Mineshita S., J. Pharmacol. Exp. Ther., 294, 822-829 (2000).
16. Chou T. C., Chang L. P., Li C. Y., Wong C. S., Yang S. P., Anesth. Analg., 97, 1724-1729 (2003).